Skip to main content
CGC
NASDAQ Life Sciences

Canopy Growth Registers 18.7M Shares for Resale by Lenders from Recent Loan Warrants

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$1.11
Mkt Cap
$401.14M
52W Low
$0.77
52W High
$2.9
Market data snapshot near publication time

summarizeSummary

Canopy Growth Corp filed an S-3 registration statement for the resale of 18.7 million common shares by selling securityholders, which are issuable upon the exercise of Loan Warrants issued as part of a recent $150 million senior secured loan.


check_boxKey Events

  • Resale Registration Filed

    Canopy Growth Corp has registered 18,705,578 common shares for resale by selling securityholders.

  • Shares from Loan Warrants

    These shares are issuable upon the exercise of Loan Warrants, which were issued to lenders on January 8, 2026, as part of a $150 million senior secured loan.

  • Warrant Exercise Price

    Each Loan Warrant has an exercise price of US$1.30 per share and will expire on January 8, 2031.

  • Potential Dilution

    The 18.7 million shares represent approximately 4.95% of the company's currently outstanding common shares, creating a potential overhang.


auto_awesomeAnalysis

This S-3 filing formalizes the ability for lenders, who received Loan Warrants as part of the $150 million senior secured loan on January 8, 2026, to resell the underlying common shares. While the company will not directly receive proceeds from these resales, the registration creates a significant overhang on the stock. The 18.7 million shares represent a notable potential dilution of approximately 4.95% of current outstanding shares. The warrants' exercise price of $1.30 is currently above the stock's closing price of $1.11, meaning they are out-of-the-money. This reduces immediate selling pressure but indicates a substantial block of shares could enter the market if the stock price recovers. This event follows a series of recent dilutive financing activities and resale registrations, highlighting the company's ongoing need for capital and the associated shareholder dilution.

At the time of this filing, CGC was trading at $1.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $401.1M. The 52-week trading range was $0.77 to $2.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CGC - Latest Insights

CGC
Mar 16, 2026, 7:59 AM EDT
Filing Type: 8-K
Importance Score:
8
CGC
Feb 13, 2026, 4:08 PM EST
Filing Type: 424B3
Importance Score:
7
CGC
Feb 06, 2026, 4:15 PM EST
Filing Type: S-3
Importance Score:
7
CGC
Feb 06, 2026, 6:45 AM EST
Filing Type: 10-Q
Importance Score:
8
CGC
Jan 15, 2026, 4:10 PM EST
Filing Type: 424B3
Importance Score:
8
CGC
Jan 09, 2026, 4:05 PM EST
Filing Type: S-3
Importance Score:
9
CGC
Jan 08, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8